Get started
Author

Michiko Imamura

Observed names: M Imamura, M. Imamura, MICHIKO IMAMURA, Michiko IMAMURA
OpenAlex ID: A5002133447
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice
2010 · Hiroko Tsutsui, Michiko Imamura, et al. · Gastroenterology Research and Practice · 77
PDF
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
2018 · Kazuhiro Araki, Yoshinori Ito, et al. · BMC Cancer · 63
PDF
Contribution of TIR domain-containing adapter inducing IFN-β-mediated IL-18 release to LPS-induced liver injury in mice
2009 · Michiko Imamura, Hiroko Tsutsui, et al. · Journal of Hepatology · 63
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel
2018 · Yoshimasa Miyagawa, Kazuhiro Araki, et al. · Clinical Breast Cancer · 55
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer
2014 · Arisa Nishimukai, Tomoko Yagi, et al. · Clinical Breast Cancer · 49
Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes
2016 · Tomoko Higuchi, Arisa Nishimukai, et al. · The Breast · 44
Mechanisms of estrogen receptor-α upregulation in breast cancers
2010 · Yasuo Miyoshi, Keiko Murase, et al. · Medical Molecular Morphology · 42
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers
2017 · Takahiro Watanabe, Akira I. Hida, et al. · Breast Cancer Research and Treatment · 37
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine
2019 · Michiko Imamura, Takashi Morimoto, et al. · Scientific Reports · 36
PDF
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
2019 · Yukie Fujimoto, Takahiro Watanabe, et al. · Breast Cancer · 35
Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer
2019 · Yukie Fujimoto, Natsuko Inoue, et al. · Cancer Science · 34
PDF
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
2018 · Michiko Imamura, Takashi Morimoto, et al. · World Journal of Surgical Oncology · 30
PDF
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer
2014 · Ayako Yanai, Natsuko Inoue, et al. · Clinical Breast Cancer · 27
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers
2015 · Yukie Enomoto, Takashi Morimoto, et al. · International Journal of Clinical Oncology · 26
Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers
2014 · Tomoko Yagi, Natsuko Inoue, et al. · Breast Cancer · 24
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy
2019 · Tomoko Higuchi, Yukie Fujimoto, et al. · Annals of Surgical Oncology · 23
PDF
Improved prognosis of low baseline neutrophil‑to‑lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes
2018 · Yukie Fujimoto, Hiromi Ozawa, et al. · Molecular and Clinical Oncology · 22
PDF
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes
2020 · AYAKO BUN, YUKIE FUJIMOTO, et al. · Anticancer Research · 21
PDF
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer
2020 · Yoshimasa Miyagawa, Ayako Yanai, et al. · Oncotarget · 21
PDF
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin
2020 · ATSUSHI SATA, REIKO FUKUI, et al. · Anticancer Research · 20
PDF
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes
2020 · REIKO FUKUI, YUKIE FUJIMOTO, et al. · Anticancer Research · 19
PDF
C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After Mastectomy
2018 · Kazuma Hashimoto, Ayano Tsuji, et al. · Anesthesiology and Pain Medicine · 19
PDF
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
2013 · Ayako Yanai, Yoshimasa Miyagawa, et al. · International Journal of Clinical Oncology · 19
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
2013 · Yoshimasa Miyagawa, Tomohiro Miyake, et al. · Breast Cancer · 14
Contribution of IL-18 to eosinophilic airway inflammation induced by immunization and challenge with Staphylococcus aureus proteins
2010 · Mai Kuroda-Morimoto, Hidehisa Tanaka, et al. · International Immunology · 14
Works count: 51
Citation count: 920
H-index: 20
I10-index: 29
Year
Topic
Type